BSE filing, NSE: SUNPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Sun Pharmaceutical Industries Ltd: key numbers
- Share price
- ₹1,769.90
- Market cap
- ₹4,24,658 Cr
- Revenue (annual)
- ₹58,462 Cr
- Net profit (annual)
- ₹11,479 Cr
- P/E (TTM)
- 38.7×Sector 47.2×
- Promoter holding
- 52.68%-1.80% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sun Pharmaceutical Industries Ltd
All →Sun Pharmaceutical Industries Price Movement Clarification
Sun Pharma said a 30 October 2026 news report concerned August 2026 developments, not new events. It confirmed no undisclosed material information explains the share price movement.
Sun Pharmaceutical Industries Annual General Meeting
Sun Pharma's postal ballot passed all seven special resolutions, including ESOP 2026 approval and borrowing and security limits. No monetary transaction is stated.
Sun Pharmaceutical Industries Earnings Call Transcript: Key Takeaways
Sun Pharma delivered resilient double-digit revenue growth despite U.S. specialty headwinds, masking underlying margin pressure from lower Lenalidomide sales.
Sun Pharmaceutical Industries Other Announcement
Sun Pharma's board appointed Deloitte as Statutory Auditors under mandatory rotation, effective from the FY 2026-27 AGM. This follows SRBC & CO's second five-year term completion.
Sun Pharmaceutical Industries Q2 FY27 Results: Net Profit ₹1,995 Cr, Down 36.2% YoY
Sun Pharmaceutical Industries Ltd reported revenue from operations of ₹16,199 Cr (+11.9% YoY) and net profit of ₹1,995 Cr (-36.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,995 Cr · -36.2% YoY
Sun Pharmaceutical Industries Regulatory Approval
Sun Pharma gained US FDA approval for ILUMYA in adults with active psoriatic arthritis. The approval extends the drug's psoriasis use, with no financial value stated.
Other merger & restructuring announcements
All →Capital Trade Links Merger & Restructuring Worth ₹0.01 Cr
Capital Trade Links incorporated wholly owned subsidiary Rentworks Services India Private Limited for renting and leasing. It subscribed 10,000 shares for Rs 1 lakh cash.
- Value
- ₹0.01 Cr
Kasturi Metal Composite Merger & Restructuring Worth ₹1.32 Cr
Kasturi Metal Composite will subscribe 51% of an unincorporated UAE flooring entity for Rs 1.32 Crore cash. The company has no operating history or turnover yet.
- Value
- ₹1.32 Cr
Ceinsys Tech Merger & Restructuring
Ceinsys Tech incorporated AASTRA AI India, a 50:50 joint venture with AI Fabrik Inc, USA. It targets sovereign AI infrastructure, with capital yet to be invested.
Kasturi Metal Composite Merger & Restructuring Worth ₹1.28 Cr
Kasturi Metal Composite's board approved incorporating a 51% owned subsidiary, Durafloor MENA LLC, in Mainland Dubai. The company will subscribe AED 5,10,000 (about Rs 1.28 Crore).
- Value
- ₹1.28 Cr
Godawari Power & Ispat Merger & Restructuring Worth ₹10.95 Cr
GPIL sold 3,67,200 Jammu Pigments shares for Rs 10.95 Crore, cutting its stake from 38.27% to 36.38%. This third tranche is part of a wider associate divestment.
- Value
- ₹10.95 Cr
Hinduja Global Solutions Merger & Restructuring
Hinduja Global Solutions updated on its subsidiary IMCL's plan to sell its entire stake in Bhima Riddhi and Vinsat to external buyers. Completion is taking longer, and both will cease to be step-down subsidiaries on completion.